Barclays’s Alimera Sciences ALIM Stock Holding History

Barclays’s Portfolio ALIM Stock Details ALIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-1,460	Closed	-$110K	–	7666
2014 Q3	$110K	Buy	+1,460	New	+$125K	﹤0.01%	5250

Barclays's ALIM Position: Q3 2024 in Review

Barclays sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 22,791 shares — an estimated $127K sold.

Barclays first reported a position in ALIM in Q2 2013 and held it in 27 quarters. The position peaked at $127K in Q2 2024. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.

Barclays reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
Barclays sold 22,791 Alimera Sciences shares in Q3 2024, an estimated $127K.
Barclays first reported a position in Alimera Sciences in Q2 2013 and held it in 27 quarters.
Barclays's Alimera Sciences position peaked at $127K in Q2 2024.
0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.

Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.